During the past decade, UCLA West Medical Pharmacy conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "UCLA West Medical Pharmacy" are "Breast Cancer" (1 trials), "Breast Neoplasms" (1 trials), "Metastatic Colorectal Cancer" (1 trials) and "Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "UCLA West Medical Pharmacy" in a lesser frequency.

Most popular intervention types in "UCLA West Medical Pharmacy" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Active Comparator (erlotinib)" (1 trials), "Cetuximab" (1 trials), "Dacomitinib (PF-00299804)" (1 trials), "Irinotecan" (1 trials) and "Letrozole" (1 trials). Other intervention names were less common.

The vast majority of trials in "UCLA West Medical Pharmacy" are 2 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "UCLA West Medical Pharmacy". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in UCLA West Medical Pharmacy, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in UCLA West Medical Pharmacy, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".